Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
British Journal of Cancer
|
May 19, 2026
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group
Isabella C Wiest, Lena Dreikhausen, Ralph Keller, et al.
Annals of Hepatology
|
October 31, 2025
MRI imaging and machine learning based radiomics for detection of mixed HCC and CCA tumors
Yuquan Qian, Qiao-Yuan Lu, Isaac Rodriguez, et al.
The Lancet. Healthy Longevity
|
September 13, 2022
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial
Matthias P Ebert, Nadja M Meindl-Beinker, Tobias Gutting, et al.
Cell Death & Disease
|
July 12, 2023
Tolerance of repeated toxic injuries of murine livers is associated with steatosis and inflammation
Seddik Hammad, Christoph Ogris, Amnah Othman, et al.
Nature Communications
|
June 6, 2022
The drug-induced phenotypic landscape of colorectal cancer organoids
Johannes Betge, Niklas Rindtorff, Jan Sauer, et al.
NPJ Genomic Medicine
|
May 29, 2024
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients
Tom Venken, Ian S Miller, Ingrid Arijs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group
Ralf-Dieter Hofheinz, Kirsten Merx, Georg M Haag, et al.
Digestion
|
October 19, 2016
Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative
Johannes Betge, Ana Barat, Verena Murphy, et al.
Biochemical and Biophysical Research Communications
|
July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
Anne Dropmann, Sophie Alex, Katharina Schorn, et al.
The American Journal of Pathology
|
May 13, 2016
Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression
Zhe Shen, Yan Liu, Bedair Dewidar, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
British Journal of Cancer
|
May 19, 2026
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group
Isabella C Wiest, Lena Dreikhausen, Ralph Keller, et al.
Annals of Hepatology
|
October 31, 2025
MRI imaging and machine learning based radiomics for detection of mixed HCC and CCA tumors
Yuquan Qian, Qiao-Yuan Lu, Isaac Rodriguez, et al.
The Lancet. Healthy Longevity
|
September 13, 2022
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial
Matthias P Ebert, Nadja M Meindl-Beinker, Tobias Gutting, et al.
Cell Death & Disease
|
July 12, 2023
Tolerance of repeated toxic injuries of murine livers is associated with steatosis and inflammation
Seddik Hammad, Christoph Ogris, Amnah Othman, et al.
Nature Communications
|
June 6, 2022
The drug-induced phenotypic landscape of colorectal cancer organoids
Johannes Betge, Niklas Rindtorff, Jan Sauer, et al.
NPJ Genomic Medicine
|
May 29, 2024
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients
Tom Venken, Ian S Miller, Ingrid Arijs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group
Ralf-Dieter Hofheinz, Kirsten Merx, Georg M Haag, et al.
Digestion
|
October 19, 2016
Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative
Johannes Betge, Ana Barat, Verena Murphy, et al.
Biochemical and Biophysical Research Communications
|
July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
Anne Dropmann, Sophie Alex, Katharina Schorn, et al.
The American Journal of Pathology
|
May 13, 2016
Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression
Zhe Shen, Yan Liu, Bedair Dewidar, et al.
Page
of 14